• InnoCare Pharma filed a next-day disclosure return to the Hong Kong Stock Exchange dated July 15, 2026.
• Issued 2,044,750 new RMB shares at RMB 6.95 under its 2023 RMB Share Incentive Scheme.
• Shanghai-listed RMB shares outstanding rose to 272,822,767 from 270,778,017.
• Hong Kong-listed shares stayed at 1,493,798,235; treasury shares unchanged at 2,486,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InnoCare Pharma Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12244659), on July 15, 2026, and is solely responsible for the information contained therein.